Goldman Sachs’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-282,693
Closed -$2.91M 5979
2023
Q2
$2.91M Hold
282,693
﹤0.01% 3582
2023
Q1
$2.87M Hold
282,693
﹤0.01% 3562
2022
Q4
$2.8M Hold
282,693
﹤0.01% 3664
2022
Q3
$2.74M Sell
282,693
-23,400
-8% -$228K ﹤0.01% 3690
2022
Q2
$2.96M Hold
306,093
﹤0.01% 3686
2022
Q1
$2.95M Buy
306,093
+274,400
+866% +$2.64M ﹤0.01% 3880
2021
Q4
$307K Buy
+31,693
New +$307K ﹤0.01% 5660

Other funds holding HWEL

Goldman Sachs's HWEL Position: Q3 2023 in Review

Goldman Sachs sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q3 2023, closing a stake of 282,693 shares — an estimated $2.91M sold.

Goldman Sachs first reported a position in HWEL in Q4 2021 and held it in 7 quarters. The position peaked at $2.96M in Q2 2022. 11 funds tracked by Wall St. Rank hold HWEL as of Q3 2023.

  • Goldman Sachs reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 282,693 Healthwell Acquisition Corp. I Class A Common Stock shares in Q3 2023, an estimated $2.91M.
  • Goldman Sachs first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • Goldman Sachs's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $2.96M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.